The Evolution of Medical Affairs in Global Pharma - Leading Beyond The Lab | Lyssna här

What does it really take to transform Medical Affairs from a scientific support function into one of the biggest strategic drivers in pharmaceutical innovation?

In this episode, Vlado Kopernicky, former Senior Vice President of International Medical Affairs at one of the world's leading pharmaceutical companies, shares how a career that began as a neonatologist evolved into helping shape one of the most significant transformations in the pharmaceutical industry.

From launching medicines across global markets to redefining the role of Medical Affairs, Vlado reflects on the leadership lessons, commercial mindset and organisational changes that supported extraordinary growth.

In this episode, Vlado covers:

03:26 How moving from clinical medicine into pharma changed the way decisions are made and why understanding business became essential.

10:27 Why Medical Affairs has evolved beyond scientific support into a strategic function responsible for accelerating the adoption of innovation across healthcare.

15:26 How Medical Affairs proved its value by measuring impact differently, and why "tell me how you measure me and I will tell you how I behave" changed the conversation.

20:19 Why focus, speed and disciplined decision making become competitive advantages, and the leadership lessons inspired by Steve Jobs' philosophy on prioritisation.

27:43 The career lessons that mattered most, from developing future leaders to recognising that long-term impact extends far beyond individual achievements.

If you're interested in pharmaceutical leadership, Medical Affairs, commercial strategy, innovation, or what it takes to build high-performing global organisations, this conversation offers practical insights from someone who has experienced transformation at the highest level.

Watch the full episode and join the discussion in the comments.

Follow ARTO

LinkedIn: / artotalent